Published in Blood Weekly, March 3rd, 2005
According to a study from Japan, "Recombinant human serum albumin (rHSA) incorporating the synthetic heme 'albumin-heme' is an oxygen-carrying plasma protein that has the potential to be a red blood cell substitute.
"The physiological responses to a 30% exchange transfusion with two types of albumin-heme (rHSA-FecycP, rHSA-FepivP) solutions after 70% isovolemic hemodilution with 5 g/dL rHSA were investigated using anesthetized rats. The circulation parameters, blood parameters, renal cortical oxygen pressure (pO2 ), and muscle tissue pO2 were carefully monitored for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.